Delisting risk
ABVE · NASDAQ · Packaged Foods

Above Food Ingredients

Seed-to-fork supplier of plant proteins, specialty ingredients, and branded foods.

$0.0301
At close−0.03 (−49.83%)
Loading prices…

Profile

Above Food Ingredients Inc. Common StockABVEConsumer Staples

Above Food Ingredients is a Canadian regenerative ingredient company listed on Nasdaq. It sources and processes grains and plant proteins for business customers while also selling branded and private-label consumer foods.

Above Food Ingredients Inc. is a Regina, Saskatchewan-based food company built around a vertically integrated seed-to-fork supply chain. Its main commercial work is split between disruptive agriculture and rudimentary ingredients, where it originates, grades, processes, and sells regeneratively grown grains and bespoke ingredients, and consumer packaged goods, where it develops owned brands and private-label products.

The company's ingredient centre supports cleaning, colour sorting, milling, blending, testing, and packaging for grains and pulses, while its brand portfolio includes Farmer Direct Organic, Culcherd, New Ocean, and NorQuin. Above Food became public through a business combination with Bite Acquisition Corp. and trades on Nasdaq under ABVE. Key dependencies include reliable crop origination, plant throughput, working capital availability, and demand from ingredient buyers, retailers, and private-label customers.

Company facts

CEOLionel Kambeitz
ListedJun 25, 2024
ExchangeNASDAQ
HeadquartersRegina, Canada
CountryCanada
CIK0001979484
ISINCA00373V1004

Key statistics

Market cap$1.5M
EPS (ttm)−$4.46
P/E (ttm)−0.0067
ROE621.6%
P/B−0.0078
P/S0.0058
Dividend yield
Beta−0.37vs XLP −8.12

Year to date −98.4% · Average volume (30d) 132.6K

Analysts

No analyst consensus on record.

Earnings

EPS

Estimate
Reported−$2.88

Revenue

Estimate
Reported$94.7M

History

Fiscal yearEPS estEPSSurpriseRevenue estRevenueSurprise
2023−$2.88$94.7M
2022−$0.42$123.7M
View details

Financial highlights

12 quartersQ1 FY23Q2 FY23Q3 FY23Q4 FY23Q1 FY24Q2 FY24
Revenue$0$0$0$68.1M$0$32.4M
Gross profit$0$0$0−$3.1M$0−$1.6M
Operating income−$888.7K−$1.1M−$481.2K−$12.3M−$556.9K−$11.7M
Net income−$727.9K−$534.1K$89.2K−$16.3M−$23.5K−$13.1M
Diluted EPS−$0.08−$0.06$0.01−$1.94−$0.00−$1.26
Gross margin-4.5%-4.9%
Operating margin-18.0%-36.0%

Fiscal years (4-quarter sums)FY22 $89.0M · FY23 $68.1M

Balance sheet, Jul 31, 2024Cash & short-term investments $478.0K · Total debt $96.3M · Total assets $80.8M · Shareholders' equity −$82.9M

Dividends

No dividends on record.

Ownership

Institutions 4.85%Insiders

Shares outstanding 51.19M · Float 42.81M · 83.6% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Arcadia Biosciences, Inc.2.74M5.08%13GAug 19, 2025
Renaissance Technologies LLC832.7K1.63%13FMay 14, 2026
Morgan Stanley501.1K0.98%13FMay 15, 2026
HRT Financial LP295.7K0.58%13FMay 14, 2026
UBS Group AG156.8K0.31%13FMay 5, 2026

Insider tradesForm 4

Nothing filed in the last 12 months.

View details

Peers

Not reported.